STERIS plc cash flow to debt ratio of 64.27% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

STERIS plc's free cash flow has increased 24.99% from $778.00M last year to $972.40M, signaling increasing performance

STERIS plc's debt to equity ratio is 0.28, which means that the company's assets are healthy financed, signaling financial stability.

STERIS plc's debt has decreased relative to shareholder equity from 0.33 last year to 0.28 today, signaling strengthened financials

STERIS plc has a net debt to EBITDA ratio of 1.03x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

STERIS plc's interest coverage ratio of 18.84 indicates that earnings with good margin can cover interest payments on company debt

STERIS plc's profit margin was 11.26% last year and is 13.34% this year, signaling increasing performance

STERIS plc's short-term assets of $2.39B exceed its short-term liabilities of $1.15B

STERIS plc's return on assets of 7.50% is higher than the 5.00% threshold, indicating efficient asset utilization

STERIS plc's return on equity of 11.27%, is lower than 15.00%, indicating bad performance

STERIS plc's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

STERIS plc had positive net income in 5 out of 5 years, indicating stable and consistent earnings

STERIS plc has positive free cash flow, indicating the company generates cash after capital expenditures

STERIS plc has a free cash flow yield of 4.78%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

STERIS plc's yearly earnings has increased 27.73% since last year from $614.64M to $785.10M, signaling increasing performance

STERIS plc's yearly revenue has increased 8.73% since last year from $5.46B to $5.94B, signaling increasing performance

ROIC 8.71% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

STERIS plc's 3-year revenue CAGR of 9.38% is positive, indicating growing revenue over the past 3 years

STERIS plc had revenue growth in 5 out of 5 years, indicating consistent revenue performance

STERIS plc had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

STERIS plc is overvalued relative to its fair value price of 158.19 based on Base Cash Flow Valuation (DCF) model

STERIS plc has an earnings yield of 3.95%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

STERIS plc is overvalued relative to its fair value price of 96.40 based on Base EBITDA Valuation model

STERIS plc has an EV/EBITDA ratio of 13.80x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

STERIS plc is overvalued relative to its fair value price of 196.87 based on Base Earnings Fair Value model

STERIS plc has a PEG-ratio over 1 which is considered overvalued

STERIS plc has a price-to-book ratio of 2.82x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

STERIS plc has a price-to-sales ratio of 3.38x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue